News | Patient Positioning Radiation Therapy | September 20, 2019

Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019

New solutions include cranial head and neck immobilization, thermoplastics and more

Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019

September 20, 2019 — Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago. Featured introductions included PositionPro, a new pitch and roll correction-enabled immobilization system for cranial and head and neck radiotherapy treatments, a new line of thermoplastics and a strapless Respiratory Compression Belt.

In addition, Aktina Medical will be showcasing its line of Interlocking Small Field Circular Cones that ensure accurate radiation dosage. The system of lead-based cones with stainless steel sleeves reduces the risk of human error by confirming the installed cone matches the programmed plan before proceeding. Also on display will be the SpiroCheck Duo automated quality assurance system for the Active Breathing Coordinator. The system ensures precise readings to within 1.25 percent and performance in critical radiotherapy planning and treatment.

Aktina’s exhibit at ASTRO 2019 also included the company’s array of non-invasive immobilization solutions including the Memorial Cradle2 for body radiosurgery, SenoView Prone Breast System, Axion 1 Carbon Fiber Breast Board and more.

For more information: www.aktina.com

Related Content

Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26 percent of patients undergoing pulmonary resection for non-small-cell lung cancer (NSCLC)

A Purdue discovery being developed by On Target Laboratories Inc., illuminates lung cancer cells on a patient during surgery. The “fluorescent markers” help medical professionals identify and remove cancer cells during surgery and is shown to improve outcomes. The technology is beginning Phase 3 clinical trials. (Photo provided by On Target)

News | Molecular Imaging | February 06, 2020
February 6, 2020 — ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
News | Clinical Trials | February 03, 2020
February 3, 2020 — Melding the genetic and cellular analysis of tumors with how they appear in medical images could g
Elekta Unity MR Linac system
News | Radiation Oncology | January 30, 2020
January 30, 2020 — Elekta announced that it signed a contract wit